Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Shareholder wants IBT break-up

Millennium Partners has called for International Biotechnology Trust to be wound up and assets returned to shareholders. Millennium (New York, N.Y.), a 10 percent shareholder, has called for

Read the full 284 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE